Vivus Llc

Vivus Llc company information, Employees & Contact Information

Explore related pages

Related company profiles:

With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. We develop high-potential molecules that have compelling safety and efficacy potential, and transform them into proprietary products that enable significant advances in patient care and outcomes. We strive to meet our goals of improving patient quality of life, giving healthcare providers new treatment options, providing a collaborative environment for our employees and creating value for our shareholders.

Company Details

Employees
176
Founded
-
Address
900 E Hamilton Ave, Campbell,california 95008,united States
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
BioPharma.
HQ
Campbell, California
Looking for a particular Vivus Llc employee's phone or email?

Vivus Llc Questions

News

VIVUS Announces QSYMIA® Price Reduction at Costco Pharmacies Nationwide - Yahoo Finance

VIVUS Announces QSYMIA® Price Reduction at Costco Pharmacies Nationwide Yahoo Finance

VIVUS Unveils Global Initiative to Advance Healthy and Sustainable Weight Management - Yahoo Finance

VIVUS Unveils Global Initiative to Advance Healthy and Sustainable Weight Management Yahoo Finance

VIVUS Shares Progress on Pipeline and Key Program Milestones During the 43rd Annual J.P. Morgan Healthcare Conference 2025 - Yahoo Finance

VIVUS Shares Progress on Pipeline and Key Program Milestones During the 43rd Annual J.P. Morgan Healthcare Conference 2025 Yahoo Finance

FDA clears label expansion for Vivus, Auxilium's erectile dysfunction therapy Stendra - FirstWord Pharma

FDA clears label expansion for Vivus, Auxilium's erectile dysfunction therapy Stendra FirstWord Pharma

GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults - Business Wire

GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults Business Wire

She Sells Vegan Chow Made for Woman’s Best Friend - The Story Exchange

She Sells Vegan Chow Made for Woman’s Best Friend The Story Exchange

Vivus Launches Obesity Drug Qsymia in UAE - NAVLIN DAILY

Vivus Launches Obesity Drug Qsymia in UAE NAVLIN DAILY

Vivus’ Qsymia gains market approval in UAE for obesity treatment - Pharmaceutical Business review -

Vivus’ Qsymia gains market approval in UAE for obesity treatment Pharmaceutical Business review -

VIVUS’ QSYMIA® to be Featured on Health Uncensored with Dr. Drew - GlobeNewswire

VIVUS’ QSYMIA® to be Featured on Health Uncensored with Dr. Drew GlobeNewswire

VIVUS and UpScriptHealth Announce Launch of ChooseQ.online for Access to Advanced Weight Management Solutions - Yahoo Finance

VIVUS and UpScriptHealth Announce Launch of ChooseQ.online for Access to Advanced Weight Management Solutions Yahoo Finance

VIVUS Launches QSYMIA® in the United Arab Emirates - GlobeNewswire

VIVUS Launches QSYMIA® in the United Arab Emirates GlobeNewswire

VIVUS Provides Update on Pipeline and Program Milestones - Yahoo Finance

VIVUS Provides Update on Pipeline and Program Milestones Yahoo Finance

VIVUS Announces it will Provide Telehealth to Patients - GlobeNewswire

VIVUS Announces it will Provide Telehealth to Patients GlobeNewswire

VIVUS Announces Commercialization of QSIVA® in Sweden, Denmark, Finland, Iceland, Norway, and Poland - GlobeNewswire

VIVUS Announces Commercialization of QSIVA® in Sweden, Denmark, Finland, Iceland, Norway, and Poland GlobeNewswire

VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P. - GlobeNewswire

VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P. GlobeNewswire

Vivus Announces FDA Approval Of STENDRA™ (avanafil) Tablets For The Treatment Of Erectile Dysfunction - Fierce Biotech

Vivus Announces FDA Approval Of STENDRA™ (avanafil) Tablets For The Treatment Of Erectile Dysfunction Fierce Biotech

In another misstep for Vivus, FDA's promo police ding misleading Qsymia webpage - Fierce Pharma

In another misstep for Vivus, FDA's promo police ding misleading Qsymia webpage Fierce Pharma

Vivus Buys U.S., Canada Rights to Pancreaze from Janssen for $135M - Genetic Engineering and Biotechnology News

Vivus Buys U.S., Canada Rights to Pancreaze from Janssen for $135M Genetic Engineering and Biotechnology News

Creating the Invisible Pen Effect in SVG using Vivus.js - SitePoint

Creating the Invisible Pen Effect in SVG using Vivus.js SitePoint

Vivus expects knockback from EMA for obesity drug - PMLiVE

Vivus expects knockback from EMA for obesity drug PMLiVE

Vivus fails to get European backing for obesity treatment Qsiva - PMLiVE

Vivus fails to get European backing for obesity treatment Qsiva PMLiVE

Reborn: Porsche Semper Vivus Hybrid Vehicle - Elektor Magazine

Reborn: Porsche Semper Vivus Hybrid Vehicle Elektor Magazine

Lohner-Porsche “Semper Vivus” on show at the Porsche Museum - flatsixes

Lohner-Porsche “Semper Vivus” on show at the Porsche Museum flatsixes

4finance Enters Mexico - NTB Kommunikasjon

4finance Enters Mexico NTB Kommunikasjon

Top Vivus Llc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant